Ruiping Wang: h-index, Total Citations, and Citation Map
Ruiping Wang's h-index is 27 (40 i10-index, 4,262+ total citations across 1+ publications) according to Google Scholar as of May 2026. Ruiping Wang is affiliated with MD Anderson Cancer Center.
Ruiping Wang is a researcher affiliated with MD Anderson Cancer Center, specializing in Cancer biology, Bioinformatics. Their work has been cited 4,262 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Ruiping Wang's Citation Metrics
Bibliometric impact based on 1 indexed publication.
- H-Index
- 27
- i10-Index
- 40
- Total Citations
- 4,262
- Citing Countries
- 5
As of May 2026.
Ruiping Wang has an h-index of 27 and 4,262 total citations across 1 publication, with research cited by institutions in 5 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Ruiping Wang's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
2020654
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher identified specific infusion product characteristics of anti-CD19 CAR T cells that correlate with clinical efficacy and toxicity in large B cell lymphoma patients.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
